| Catalog | name | Description | price |
|---|---|---|---|
| R-M2-9811 | DMG-PEG2K-SFHQFARATLAS | DMG-PEG2K-SFHQFARATLAS is a peptide conjugate. Applications: Targeted liposomal delivery systems (e.g., for drugs, siRNA, or imaging agents); Nanoparticle surface functionalization for enhanced selectivity; Theranostic carriers combining therapy and imaging; Peptide-mediated endocytosis or receptor binding. | price> |
| R-M2-9812 | CHOL-PEG5K-GPC3(PHLASLWWGTEL) | CHOL-PEG5K-GPC3 Targeted Peptide (PHLASLWWGTEL)/Cholesterol-PEG5K-GPC3 Targeted Peptide(PHLASLWWGTEL)/Cholesterol-PEG5K-GPC3(PHLASLWWGTEL)/Cholesterol-PEG5K-PHLASLWWGTEL is a cholesterol-PEG-peptide conjugate designed for targeted delivery. Applications: Targeted liposomal drug delivery for liver cancer (HCC). Diagnostic imaging probes targeting GPC3-overexpressing tissues. Theranostic carriers combining therapy and imaging in HCC. Can be used to deliver siRNA, chemotherapeutics, or photosensitizers selectively to tumor cells. | price> |
| R-M2-9813 | DMG-PEG5K-GPC3(PHLASLWWGTEL) | DMG-PEG5K-GPC3 Targeted Peptide (PHLASLWWGTEL)/DMG-PEG5K-GPC3 Targeted Peptide(PHLASLWWGTEL)/DMG-PEG5K-GPC3(PHLASLWWGTEL) is a peptide conjugate designed for targeted delivery. Applications: Targeted liposomal drug delivery for liver cancer (HCC). Diagnostic imaging probes targeting GPC3-overexpressing tissues. Theranostic carriers combining therapy and imaging in HCC. Can be used to deliver siRNA, chemotherapeutics, or photosensitizers selectively to tumor cells. | price> |
| R-M1-8215 | Cholesterol-PEG-FCIGRLGGGGGGC | Cholesterol-PEG-FCIGRLGGGGGGC is a bifunctional peptide modified peg reagent. | price> |
| R-M1-8221 | DMG-PEG2K-PKTRNSQTQTDRRRRRRRR | DMG-PEG2K-PKTRNSQTQTDRRRRRRRR is a Peptide modified heterobifunctional peg reagent. | price> |
| R-M2-9863 | DMG-PEG-THRPPMWSPVWP | DMG-PEG-THRPPMWSPVWP is a peptide conjugate.This amphiphilic construct allows stable incorporation into liposomal or nanoparticle systems, providing both biocompatibility and active targeting functionality. Applications: Targeted liposomal drug delivery with enhanced selectivity. Nanoparticle surface functionalization for receptor-mediated uptake. Cellular imaging or diagnostic probes when combined with fluorescent or therapeutic cargo. Theranostic nanomedicine integrating targeting, imaging, and therapy. | price> |
| R-M2-9864 | CHOL-PEG-THRPPMWSPVWP | CHOL-PEG-THRPPMWSPVWP/Cholesterol-polyethylene glycol-THRPPMWSPVWP is a peptide conjugate.The cholesterol moiety enables stable insertion into lipid bilayers or micelles, while PEG provides hydrophilicity and steric stabilization, and the THRPPMWSPVWP sequence acts as a targeting peptide (often used to recognize tumor or disease-related receptors). Applications: Targeted drug delivery (liposomes, micelles, exosomes). Theranostic nanoparticles for tumor imaging and therapy. Surface functionalization of lipid or polymeric carriers to improve cell-specific uptake. | price> |
| R-M2-9865 | DMG-PEG-THRPPMWSPVWP-NH2 | DMG-PEG-THRPPMWSPVWP-NH2 is a peptide conjugate. Applications: Targeted liposomal drug delivery (smallmolecules, siRNA, peptides). Theranostic nanocarriers with imaging agent attachment. SurfaceDMG-PEG-THRPPMWSPVWP-NH2 is a peptide conjugate. Applications: Targeted liposomal drug delivery (smallmolecules, siRNA, peptides). Theranostic nanocarriers with imaging agent attachment. Surface functionalization of liposomes, polymersomes, or hybrid nanoparticles. functionalization of liposomes, polymersomes, or hybrid nanoparticles. | price> |
| R-M2-9866 | CHOL-PEG-THRPPMWSPVWP-NH2 | CHOL-PEG-THRPPMWSPVWP-NH2is a peptide conjugate. Applications: Targeted liposomal drug delivery (smallmolecules, siRNA, peptides). Theranostic nanocarriers with imaging agent attachment. Surface functionalization of liposomes, polymersomes, or hybrid nanoparticles. | price> |
| R-M2-9868 | LPGA8K-PEG2K-CTHRSSWC | LPGA8K-PEG2K-CTHRSSWC is a peptide conjugate.This structure combines biocompatibility, water solubility, and peptide-mediated active targeting, making it suitable for drug delivery and nanomedicine applications.Linear poly(L-glutamic acid) is a biodegradable, water-soluble polypeptide composed of repeating L-glutamic acid residues linked through α-peptide bonds. The polymer backbone provides multiple carboxyl groups that can be used for drug conjugation, crosslinking, or surface modification. Applications: Targeted drug delivery (chemotherapeutics, siRNA, imaging agents). Nanoparticle surface functionalization for active tumor targeting. Development of stimuli-responsive polymeric carriers in cancer therapy. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


